Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002414837 | SCV002716678 | pathogenic | Hereditary cancer-predisposing syndrome | 2018-05-21 | criteria provided, single submitter | clinical testing | The c.1728_1746dup19 variant, located in coding exon 11 of the MSH2 gene, results from a duplication of CATTGTTAAAGAAATTGTC at nucleotide position 1728, causing a translational frameshift with a predicted alternate stop codon (p.N583Hfs*3). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |